ArticleJournal of healthcare engineering2022
Noninvasive Spectroscopic Detection of Blood Glucose and Analysis of Clinical Research Status.
Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 6 citations in OpenAlex.
- Retracted: Noninvasive Spectroscopic Detection of Blood Glucose and Analysis of Clinical Research Status.Journal of healthcare engineering · 2023Article
Corrections and comments
- Retraction · 2023-07-12Concerns/Issues about Data · Concerns/Issues about Results and/or Conclusions · Concerns/Issues about Referencing/Attributions · Concerns/Issues about Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Paper Mill · Computer-Aided Content or Computer-Generated Content · Unreliable Results and/or Conclusions · · See also: https://pubpeer.com/publications/5362F2A61498F7C630CACAD6DA4736
- Retracted
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Frequent measurement of blood glucose concentration in diabetic patients is an important means for diabetes control. Blood glucose monitoring with noninvasive detection technology can not only avoid the pain of patients and eliminate the harm of some biological materials for measuring glucose in vivo but also improve the frequency of detection, so as to control blood glucose concentration more closely. Traditional blood glucose detection methods are invasive and have some limitations. In this study, the significance of noninvasive blood glucose testing was analyzed and was pointed out that noninvasive blood glucose testing can monitor the blood glucose concentration of patients and relieve the pain of patients. Then, this study analyzed the spectral detection methods of noninvasive blood glucose, including conservation of energy metabolism, near infrared spectroscopy, and other spectral detection methods. Finally, this study made a comprehensive analysis of the domestic and international clinical application of noninvasive glucose spectrum monitoring and summarized the clinical application status of noninvasive glucose spectrum monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.